Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients

References

• Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000;11:912–6.
   PubMed Web of Science ®Google Scholar
• Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125–34.
   PubMed Web of Science ®Google Scholar
• Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008;4:80–90.
   PubMedGoogle Scholar
• Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocri 2003;17:2386–93.
   PubMed Web of Science ®Google Scholar
• Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008;11:7–12.
   PubMed Web of Science ®Google Scholar
• Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002;61:638–47.
   PubMed Web of Science ®Google Scholar
• Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004;5:2959–64.
   Google Scholar
• Andress DL. Vitamin D in chronic kidney disease. A systemic role for selective vitamin D receptor activation. Kidney Int 2006;69:33–43.
   PubMed Web of Science ®Google Scholar
• Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726–76.
   PubMed Web of Science ®Google Scholar
• Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008;149:558–64.
   PubMed Web of Science ®Google Scholar
• Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005;288:125–32.
   PubMed Web of Science ®Google Scholar
• Marco MP, Craver L, Betriu A, Fibla J, Fernández E. Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38: 965–74.
   PubMed Web of Science ®Google Scholar
• Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, Thadhani R, Zoccali C. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res 2010;25:313–9.
   PubMed Web of Science ®Google Scholar
• Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, Wanner C, Boeschoten EW, Brandenburg V; NECOSAD Study Group. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011;26:1024–32.
   PubMed Web of Science ®Google Scholar
• García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, Guerra R, Perez MA, Fernández E, Toledo A, Lago M, Checa MD. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 2011;26:2250–6.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, Kawano Y. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kid Dis 2002;40:974–82.
   PubMed Web of Science ®Google Scholar
• Rakowski H, Appleton C, Chan K, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O’Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: From the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiography 1996;9:736–60.
   PubMedGoogle Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613–8.
   PubMed Web of Science ®Google Scholar
• Palatini P, Penzo M, Bongiovi S, Canali C, Pessina AC. Role of ophthalmoscopy in arterial hypertension: a problem revisited. Cardiologia 1991;36:713–22.
   PubMedGoogle Scholar
• de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995;25:1056–62.
   PubMed Web of Science ®Google Scholar
• Covic A, Voroneanu L, Goldsmith D. The effects of vitamin D therapy on left ventricular structure and function – Are these the underlying explanations for improved CKD patient survival? Nephron Clin Pract 2010;116:c187–95.
   PubMedGoogle Scholar
• Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, Sahin F, Haberal M. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc 2005;37: 2922–4.
   PubMed Web of Science ®Google Scholar
• Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis 1998;32:464–9.
   PubMed Web of Science ®Google Scholar
• Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S. Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail 2010;32:969–77.
   PubMed Web of Science ®Google Scholar
• Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006;371:1–12.
   PubMed Web of Science ®Google Scholar
• Ertürk S, Kutlay S, Karabulut HG, Keven K, Nergizoglu G, Ates K, Bokesoy I, Duman N. The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients. Am J Kidney Dis 2002;40:816–23.
   PubMed Web of Science ®Google Scholar
• Strózecki P, Adamowicz A, Nartowicz E, Odrowaz- Sypniewska G, Włodarczyk Z, Manitius J. Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail 2001;23:115–26.
   PubMed Web of Science ®Google Scholar
• Chow KM, Szeto CC, Kum LC, Kwan BC, Fung TM, Wong TY, Leung CB, Li PK. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 2003;16:878–85.
   PubMed Web of Science ®Google Scholar
• Fujii H, Kim JI, Abe T, Umezu M, Fukagawa M. Relationship between parathyroid hormone and cardiac abnormalities in chronic dialysis management. Intern Med 2007;46:1507–12.
   PubMed Web of Science ®Google Scholar
• Fellner SK, Lang RM, Neumann A, Bushinsky DA, Borow KM. Parathyroid hormone and myocardial performance in dialysis patients. Am J Kidney Dis 1991;18: 320–5.
   PubMed Web of Science ®Google Scholar
• Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y. Lower risk for cardiovascular mortality in oral 1- hydroxy vitamin D users in a haemodialysis population. Nephrol Dial Transplant 2004;19:179–84.
   PubMed Web of Science ®Google Scholar
• Goldsmith DJ, Covic A, Sambrook PA, Ackrill P. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 1997;77:37–43.
   PubMed Web of Science ®Google Scholar
• Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990;258:E134–42.
   PubMedGoogle Scholar
• Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996;97:1577–88.
   PubMed Web of Science ®Google Scholar
• Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 2007;103:533–7.
   PubMed Web of Science ®Google Scholar